Pharmacogenetics, race and global injustice. Developing world bioethics [Dev World Bioeth] Journal article

Title	Pharmacogenetics, race and global injustice.
Author(s)	Holm S
Institution	Cardiff Law School, Cardiff University, Museum Avenue, Cardiff CF10 3XJ, United Kingdom. holms@cardiff.ac.uk
Source	Dev World Bioeth 2008 Aug; 8(2):82-8.
MeSH	African Americans Continental Population Groups Delivery of Health Care Developing Countries Drug Combinations Heart Failure Humans Hydralazine Internationality Isosorbide Dinitrate Pharmacogenetics Social Justice United States United States Food and Drug Administration
Abstract	This paper discusses the link between pharmacogenetics and race, and the global justice issues that the introduction of pharmacogenetics in pharmaceutical research and clinical practice will raise. First, it briefly outlines the likely impact of pharmacogenetics on pharmaceutical research and clinical practice within the next five to ten years and then explores the link between pharmacogenetic traits and 'race'. It is shown that any link between apparent race and pharmacogenetics is problematic and that race cannot be used as a proxy for pharmacogenetic knowledge. The final section considers the implications of the development of pharmacogenetics for health care systems in low- and middle-income countries.
Language	eng
Pub Type(s)	Journal Article
PubMed ID	19143085

Advertise on this site.